Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
Around 100 far-right activists have staged an unauthorised demonstration in Nice waving French flags and singing La Marseillaise on the steps of the M...
Read More
A high school student has been arrested after police found two switchblade knives in his bag during a security check at the school entrance in Menton,...
Read More
France is bracing itself for major strike action this week. This Thursday the 18th of September, schools may close, transport workers will strike, cau...
Read More
A major union representing French air traffic controllers has cancelled its strike notice for 18 September...
Read More
Monaco’s new Minister of State, Christophe Mirmand has given his first press conference since taking office, pledging to serve with humility, transpar...
Read More
